GlassScriptPhysician profile
Megan Mcclean
NPI 1356730055
$12,608.84
in general payments reported to CMS, 2019-2025
20 companies · $582 in 2025
The $582 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $158 · 2021: $47.66 · 2022: $10K · 2023: $390 · 2024: $362 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $9,715.38 | 2019-2025 | |
| Merz North America, INC. | $1,497.08 | 2020-2025 | Xeomin |
| Allergan, INC. | $454.01 | 2019-2022 | |
| Galderma Laboratories, L.P. | $292.50 | 2022-2025 | Aklief |
| Solta Medical, A Division of Bausch Health US, LLC | $156.57 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $88.41 | 2019 | |
| Janssen Scientific Affairs, LLC | $82.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $46.67 | 2020-2025 | |
| Lilly USA, LLC | $43.65 | 2024 | Olumiant, Ebglyss, Taltz |
| Journey Medical Corporation | $39.96 | 2025 | |
| Biowound Solutions, INC. | $28.99 | 2025 | Bio-Connekt |
| Biofrontera INC. | $23.82 | 2024 | Xepi, Bf-Rhodoled, Rhodoled Xl |
| Leo Pharma INC. | $22.62 | 2022 | |
| Incyte Corporation | $22.24 | 2024 | Opzelura |
| Medtronic, INC. | $21.02 | 2025 | Azure Xt Dr Mri Surescan |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $20.96 | 2024 | |
| Genzyme Corporation | $18.09 | 2024 | |
| Dusa Pharmaceuticals, INC. | $16.26 | 2019 | |
| Botanix Sb INC | $15.58 | 2025 | Sofdra |
| Epi Health, LLC | $2.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Mcclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.